Tuesday November 27th, 8:00-9:30 AM
CATEGORY: ROUTINE AND EXPANDED TESTING
HIV Diagnostics and Testing
Moderators Bernie Branson, Centers for Disease Control and Prevention
Jenny McFarlane, Texas Department of State Health Services
HIV Diagnostics and Testing Update
Bernie Branson, Centers for Disease Control and Prevention
Internal Evaluation of the Bio-Rad GEENIUS HIV 1/2 Supplemental Assay
Christopher Bentsen, Bio-Rad Laboratories
Performance Characteristics of ADVIA Centaur HIV Ag/Ab Combo (CHIV) assay for the simultaneous detection of HIV p24 Antigen and Antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma
Lawrence Baker, Siemens Healthcare Diagnostics
Scaling Up Community-based HIV Antibody and RNA Testing among Gay Men in San Francisco
Steve Gibson, San Francisco AIDS Foundation
An algorithm using electronic medical record data accurately identifies patients with unknown HIV status in a large, urban healthcare system
Uriel Felsen, Albert Einstein College of Medicine/ Montefiore Medical Center
Routine Opt-Out HIV Screening on the U.S. – Mexico Border, Opportunities for Diagnosis and Prevention
Robert Woolard, Texas Tech University Health Sciences Center
Novel Emergency Department Registration Kiosk for HIV Screening Increases Engagement of High Risk Patients
Yu-Hsiang Hsieh, The Johns Hopkins University
Point-of-sex testing: Intentions of men who have sex with men to use home-use HIV tests with sex partners
David Katz, University of Washington
CATEGORY: PREVENTION MODELS
Pre-Exposure Prophylaxis for HIV Prevention
Moderators Kenneth H. Mayer, The Fenway Institute & Beth Israel Deaconess Medical Center
Sheryl Zwerski, Division of AIDS, National Institutes of Health
Overview of PrEP
Kenneth Mayer, The Fenway Institute
Development of a PrEP Candidate Screening Tool: An Assessment of PrEP Knowledge and Health Behaviors among Individuals at High-Risk for HIV
Amanda Castel, George Washington University School of Public Health & Health Services
Provider Knowledge, Use, and Barriers to the Uptake of PEP and PrEP
Amanda Castel, George Washington University School of Public Health & Health Services
HIV pre-exposure prophylaxis (PrEP): knowledge and attitudes among a New York City emergency department patient population
Ethan Cowan, Jacobi Medical Center, Einstein Medical Center
How to implement PrEP
Sean Cahill, The Fenway Institute
Near-perfect adherence in US iPrEx RCT sites: Frequency and Correlates.
K Rivet Amico, Applied Health Research; Center for Health Intervention and Prevention
Building a culturally tailored PrEP demonstration program for young men who have sex with men of color: Lessons Learned from the CRUSH Project in Oakland, California
Kimberly Koester, University of California, San Francisco
CATEGORY: OUTCOMES AND IMPACT EVALUATION
Surveillance, Observational Databases, and Cohorts
Moderators Daniel Church, Massachusetts Department of Public Health
Veronica Miller, Forum for Collaborative HIV Research
Follow-up testing for hepatitis C virus infection: An analysis of Massachusetts surveillance data from 2007-2010
Daniel Church, Massachusetts Department of Public Health
Chronic Hepatitis Cohorts Study (CHeCS)
Scott Holmberg, Centers for Disease Control and Prevention
VA Clinical Case Registry of HCV Patients
Lisa Backus, Department of Veterans Affairs
Kaiser Permanente Viral Hepatitis Registry
Michele Manos, Kaiser Permanente
Longitudinal Cohorts of Alaska Native and American Indian Persons with Chronic Hepatitis B or Hepatitis C
Lisa Townshend, Alaska Native Tribal Health Consortium
Mapping the co-occurrence of HIV, hepatitis C, and chlamydia in New York City (NYC) to support targeted testing at Federally Qualified Health Centers (FQHCs)
Jennifer Fuld, New York City Department of Health and Mental Hygiene
State of the ART: Characteristics of HIV infected patients receiving care in Mississippi (MS), USA from the Medical Monitoring Project, 2009-2010
Arti Barnes, University of Mississippi Medical Center
Using cross-matched HIV and sexually transmitted disease registry data to estimate adherence to dual screening recommendations in New York City
Colin Shepard, New York City Department of Health and Mental Hygiene
CATEGORY: ACCESS, LINKAGE AND RETENTION IN CARE
Access to Care for Persons with HIV and Viral Hepatitis: Policy Forum
Moderators Andrea Weddle, HIV Medicine Association
Seiji Hayashi, HRSA, BPHC
Expanding Access to Care for Persons with HIV and Viral Hepatitis: Opportunities and Challenges for Health Centers
Seiji Hayashi, HRSA, BPHC
HIV/AIDS and Hepatitis Health Department Collaborations with Community Health Centers: Successes and Challenges
Liisa Randall, National Alliance of State and Territorial AIDS Directors
Opportunities for Improving Access: Ryan White Reauthorization
Bill McColl, AIDS United
Streamlining and Improving Access to Industry Patient Assistance Programs - A Collaboration Between HarborPath, NASTAD and the Clinton Health Access Initiative (CHAI)
Murray C. Penner, National Alliance of State and Territorial AIDS Directors and Ken Trogdon, President and CEO of HarborPath
The State Healthcare Access Research Project on Access to Care for Persons Living with Hepatitis C In Massachusetts
Malinda Ellwood, Harvard Law School Center for Health Law and Policy Innovation
Patterns and Correlates of Linkage to Appropriate HIV Care following HIV Diagnosis in the U.S. Medicaid Population
Timothy Juday, Bristol-Myers Squibb
Impact of payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the United States
Timothy Juday, Bristol-Myers Squibb
Tuesday November 27th, 9:45 – 11:15 AM
CATEGORY: ROUTINE AND EXPANDED TESTING
HCV Diagnostics and Birth Cohort Testing
Moderators Chong-Gee Teo, Centers for Disease Control and Prevention
Jane Getchell, Association of Public Health Laboratories
HCV Diagnostics and Testing Update
Chong-Gee Teo, Centers for Disease Control and Prevention
CDC’s Evidence-Based Recommendations for the Identification of Hepatitis C Virus (HCV) Infection among Persons Born during 1945-1965 in the United States
Bryce Smith, Centers for Disease Control and Prevention
Indications for Testing among Reported Cases of Hepatitis C Virus Infection from Enhanced Hepatitis Surveillance Sites—United States, 2004–2010
Reena Mahajan, Centers for Disease Control and Prevention
Rates of Hepatitis C Virus Testing among US Veterans in Department of Veterans Affairs Care, 2011
Lisa Backus, Department of Veterans Affairs
Testing Preferences and Knowledge of HBV and HCV among a New York City Emergency Department Patient Population
Ethan Cowan, Jacobi Medical Center, Einstein Medical Center
Hepatitis C Antibody Testing and Follow-up in Primary Care Settings: A Retrospective Study of Four Large, Primary Care Service Centers
David Rein, NORC at the University of Chicago
CATEGORY: PREVENTION MODELS
Population Approaches to Prevention
Moderators Daniel Raymond, Harm Reduction Coalition A. Cornelius Baker, National Black Gay Men’s Advocacy Coalition
Preparing for and conducting a successful HCV vaccine trial with injection drug users
Alice Asher, University of California San Francisco
Young adults at risk for HCV: Meeting their needs through the UFO Model prevention program
Alice Asher, University of California San Francisco
Hepatitis Outreach Network: A Practical Strategy for Hepatitis Screening with Linkage to Care in Foreign Born communities
Ponni Perumalswami, Mount Sinai School of Medicine
Sustaining Vital Linkages Between Community and Clinical settings for MSM
James Murphy, AIDS Action Committee of Massachusetts
Mapping the U.S. HIV Epidemic: How Can AIDSVu be a Resource for Achieving the National AIDS Strategy?
Patrick Sullivan, Rollins School of Public Health, Emory University
A Best-Practice Community-Based Approach to Hepatitis Prevention for At-Risk Immigrant and Refugee Communities
Mona El-Shamaa, Asian Health Coalition
CATEGORY: OUTCOMES AND IMPACT EVALUATION
Clinical and Cost-Effectiveness Research
Moderators Rochelle Walensky, Harvard Medical School and Massachusetts General and Brigham & Women's Hospitals
Bruce Schackman, Weill Cornell Medical College
Cost-effectiveness analyses of ARV genericization in HIV care
Rochelle Walensky, Harvard Medical School/Massachusetts General and Brigham & Women's Hospitals
Cost-effectiveness and HCV
Bruce Schackman, Weill Cornell Medical College
A Cost-Effectiveness Analysis of the Washington, D.C. Department of Health’s HIV/AIDS Testing and Linkage to Care Programs
John Wedeles, George Washington University School of Public Health and Health Services
Cost Analysis of Positive Charge, a Multi-Site Linkage to Care Program
J. Janet Kim, Johns Hopkins Bloomberg School of Public Health
Persons Diagnosed and Living with HIV/AIDS (PDLWH/A) who can Potentially Transmit HIV through Heterosexual Contact in Pennsylvania, 2010
Persons Diagnosed and Living with HIV/AIDS (PDLWH/A) who can Potentially Transmit HIV through Men having Sex with Men (MSM) in Pennsylvania, 2010
Benjamin Muthambi, Pennsylvania Department of Health
Linkage, Engagement and Viral Suppression Rates among HIV-Infected Persons Receiving Care at Medical Case Management Programs in Washington, DC
Sarah Willis, George Washington University
Sustained virologic response and the development of hepatocellular carcinoma (HCC) among persons with chronic hepatitis C virus (HCV) infection: a meta-analysis of observational studies
Rebecca Morgan, Centers for Disease Control and Prevention
Estimating averted HIV-related medical costs on the path to eliminating mother-to-child transmission among HIV-infected pregnant women in New York State: 1998-2010
Franklin Laufer, AIDS Institute, New York State Department of Health
CATEGORY: ACCESS, LINKAGE AND RETENTION IN CARE
HCV Workforce Capacity: Models and the HCV Workforce
Moderators David Thomas, Johns Hopkins School of Medicine
Sanjeev Arora, University of New Mexico Health Sciences Center
Project ECHO: Outcomes of Hepatitis C Treatment by Primary Care Providers
Karla Thornton, Univ of New Mexico Health Sciences Center
Who's providing HCV Care at Kaiser
Michele Manos, Kaiser Permanente
Increasing the Capacity to Treat Hepatitis C and HIV in Primary Care using the Project ECHO Model in a FQHC
Khushbu Khatri, Community Health Center, Inc.
Alaska LiverConnect: Providing Remote Specialty Liver Disease Education
James Gove, Alaska Native Tribal Health Consortium
Panelist: David Ross, Department of Veterans Affairs
Panelist: Colleen Flanigan - New York State Department of Health
Tuesday November 27th, 1:15 – 3:15 PM
CATEGORY: ROUTINE AND EXPANDED TESTING
Models for HIV and HCV Testing
Moderators Lorren Sandt, Caring Ambassadors Program, Inc.
Joanne Stekler, University of Washington & Public Health – Seattle King CountyHIV/STD Program
Feedback from HIV/HCV DX Roundtable
Nivedha Panneer, University of California, Berkeley
Acceptability and implications of rapid HCV test among high risk young injection drug users
Kimberly Page, University of California, San Francisco
The Impact of HCV Rapid Testing on Individuals Knowledge of their HCV Status
Colleen Flanigan, New York State Department of Health
Routine HIV Testing at Montefiore Medical Center: Scale-up Case Studies from New York City's Second Largest Hospital System
Donna Futterman, Montefiore Medical Center
Building Sustainable Universal HIV Screening Programs in Pediatric Emergency Departments: A Comparison
Jun Payne, Children's National Medical Center
Preliminary Results from 'Do One Thing:' A comprehensive neighborhood-based HIV and HCV testing, prevention and media campaign in Southwest Philadelphia
Stacey Trooskin, Drexel University College of Medicine
Transmission Network Targeting: Incorporating Social Network and Partner Testing with an Emergency Department HIV Screening Program
Robbie Paulsen, University of Cincinnati College of Medicine
CROSS-CUTTING SESSION
Viral Hepatitis and HIV Prevention, Diagnosis and Access to Care and Correctional Settings
Moderators Barry Zack, The Bridging Group
Feasibility and Acceptability of Hepatitis C Virus Counseling and Rapid Testing in a Criminal Justice Setting
Curt Beckwith, Alpert Medical School of Brown University & The Miriam Hospital
Who better than us? Recruiting individuals with histories of incarceration and substance abuse to increase access to HIV and HCV testing and linkage to care
Terrence Young, Community Education Group
Project ECHO’s (Extension for Community Health Outcomes) Prisoner Health is Community Health: The New Mexico Peer Education Project (NM PEP)
Karla Thornton, University of New Mexico Health Sciences Center
HIV and viral hepatitis prevention and screening in correctional settings
James Sosman, University of Wisconsin
CATEGORY: OUTCOMES AND IMPACT EVALUATION
Outcomes and Epidemiology
Moderators Daniel Seekins, Bristol-Myers Squibb
Amy Lansky, Centers for Disease Control and Prevention
Estimating the Number of Injection Drug Users in the United States to Calculate National Rates of HIV Infection
Amy Lansky, Centers for Disease Control and Prevention
Newly Diagnosed Positives Identified by HIV Testing Programs in New York City
Andrea King, New York City Department of Health and Mental Hygiene
Missed opportunities in HIV testing in New York City
Andrea King, New York City Department of Health and Mental Hygiene
Endocarditis as a sentinel marker for new epidemics of injection drug use and hepatitis c virus infection
Susana Keeshin, University of Cincinnati
Routine HIV Testing As a Vital Sign - Two Years’ Experience
Gebeyehu Teferi, Unity Health Care
Routine HIV testing and linkage to care services offered at Public Aid offices can help identify undiagnosed HIV infections and facilitate linkage to HIV care in urban high risk minority communities
Tomas Soto, AIDS Foundation of Chicago
Mortality trends among people reported with hepatitis C virus infection: Massachusetts, 1992-2009
Daniel Church, Massachusetts Department of Public Health
Dynamic trends in HIV/AIDS diagnoses and related biological, sexual, and drug use risk factors among adolescents in Washington, DC
Yujiang Jia, HIV/AIDS, Hepatitis, STD and TB Administration, DC Department of Health
CATEGORY: ACCESS, LINKAGE AND RETENTION IN CARE
HIV Care and Treatment: Who are and who will be the Providers?
Moderators John Bartlett, Johns Hopkins School of Medicine
Steve Boswell, The Fenway Institute
Current estimates are that only 37 to 50 percent of people with HIV are in regular care. While the National HIV/AIDS Strategy and the Affordable Care Act provide the opportunity to significantly increase the number of people with HIV who enter the care system, workforce and care capacity constraints may continue to limit access to effective HIV care. The goal of this panel is to discuss opportunities for, and challenges to, expanding HIV care capacity. Issues such as the role of primary care providers, federally‐qualified community health centers, academic health centers and community‐based providers will be discussed along with the with the sustainability of the comprehensive HIV care model in a new health care financing environment.
Panelists
Kathy McNamara, National Association of Community Health Centers
Michael Horberg, Kaiser Permanente
Lisa Fitzpatrick, United Medical Center
Donna Sweet, University of Kansas School of Medicine
Brian Toomey, Piedmont Health Services
Joe Burrage, Indiana University School of Nursing, American Academy of Nursing
Tuesday November 27th, 3:30 – 4:50 PM
CATEGORY: ROUTINE AND EXPANDED TESTING
Testing Integration in the Primary Care Setting
Moderators Judith Feinberg, University of Cincinnati College of Medicine
James Sosman, University of Wisconsin School of Medicine and Public Health
Testing among Primary Care Providers
James Sosman, University of Wisconsin
Primary care physician implementation of routine HIV screening in Washington, DC: An Assessment of Perceptions, Challenges and Barriers
Lisa Fitzpatrick, United Medical Center
HIV Testing Practices Differ among Black Primary Care Physicians in the US According to Physician Characteristics and Patient Demographics
Bryan Baugh, Janssen Therapeutics
Integrating Routine HIV Testing in Primary Care
Vanessa Rodriguez, Urban Health Plan, Inc.
Hepatitis C Virus Screening Practices among Primary Care Physicians in Four Large Primary Care Settings
Amy Jewett, Centers for Disease Control and Prevention
CATEGORY: PREVENTION MODELS
Focus on HIV Prevention for Most-at-Risk Populations
Moderators Greg Millett, Centers for Disease Control and Prevention
Victoria Cargill, Office of AIDS Research, National Institutes of Health
HIV and African American Men who have Sex with Men
Greg Millett, Centers for Disease Control and Prevention
HIV and Women
Sally Hodder, New Jersey Medical School
HOME: A holistic approach to HIV prevention and program evaluation for young MSM of color in New York City
Sherry Estabrook, Harlem United Community AIDS Center
Racial Disparities in Unprotected Sex, HIV Infections, and Engagement in Care, Viral Load Suppression among Individuals living with HIV in Hyperendemic MSM Community of Washington DC
Yujiang Jia, HIV/AIDS, Hepatitis, STD and TB Administration
CATEGORY: ROUTINE AND EXPANDED TESTING
Policy Issues Affecting HIV and HCV Testing
Moderators Corinna Dan, Department of Health and Human Services
HIV Testing in the Emergency Department (ED): Financing and Reimbursement
Rich Rothman, Johns Hopkins University
Routine HIV Testing in the US Department of Veterans Affairs (VA): Impact of National Policy Change and Operational Interventions 2009-2011
Maggie Czarnogorski, Department of Veterans Affairs
Increasing Routine Viral Hepatitis Testing: Technical Consultation Report Findings
Corinna Dan, Department of Health & Human Services
Opportunities for Expanding HIV Testing Through Health Reform
Lindsey Dawson, The AIDS Institute
Expanding Our Reach: State and Local Health Department Efforts to Increase Access to and Utilization of HIV and HCV Testing
Liisa Randall, National Alliance of State and Territorial AIDS Directors
Extent of Hepatitis C Screening and HIV Testing and Linkage to Care Services among Substance Use Treatment Programs in New York City
Shruti Ramachandran, NYC Department of Health and Mental Hygiene
Reducing barriers to HIV testing – what influences testing offer and uptake? Lessons learned from the HIV in Europe Initiative
Dorthe Raben, Copenhagen HIV Programme
Barriers and Facilitators to HIV and Hepatitis C Testing among Active Intravenous Drug Users
Joshua Barocas, University of Wisconsin-Madison
CATEGORY: ACCESS, LINKAGE AND RETENTION IN CARE
Care Models that Support Linkage and Retention in Care
Moderators Julie Dombrowski, University of Washington and Public Health - Seattle & King County HIV/STD Program
Carol Brosgart, Centers for Disease Control and Prevention
Testing, linkage and Retention in Care: Getting Control of the Cascade in Seattle, WA
Julie Dombrowski, University of Washington
Reaching and Retaining Co-Infected HIV/HCV Residents in Underserved Communities
Kimberly Gilgenberg, Tenderloin Area Center of Excellence
Utility of identifying out of care HIV-infected patients in a hospital setting and enrolling them in a retention intervention
Jessica Davila, Baylor College of Medicine
in+care Campaign: a national virtual collaborative to improve retention
Michael Hager, New York State Department of Health AIDS Institute
Linkage to HIV Care in the VA Healthcare System
Thomas Giordano, Houston VAMC and Baylor College of Medicine
Increasing Retention in Care for HIV+ Homeless Individuals: Harlem Model Implementation
Expedito Aponte, Harlem United Community AIDS Center, Inc.
Check Hep C: A Demonstration Project for Providing Comprehensive Community-Based Screening, Linkage and Medical Services to New Yorkers with or at Risk for Chronic Hepatitis C Infection
Ashly Jordan, NYC Department of Health and Mental Hygiene
Using surveillance data to identify HIV-infected persons out-of-care in New York City and offer linkage to care and HIV partner services
Colin Shepard , NYC Department of Health and Mental Hygiene
Engagement in Care applied to US Department of Veterans Affairs (VA): HIV virologic outcomes in an integrated health care system.
Maggie Czarnogorski, Department of Veterans Affairs
